The multi-year capital equipment deal gives eligible Vizient clients contracted pricing on a system designed to support acute kidney injury assessment in critically ill patients.


Accuryn Medical has entered a multi-year capital equipment supplier agreement with Vizient for advanced fluid monitoring, the company announced.

Under the agreement, eligible Vizient clients can access contracted pricing and negotiated purchasing terms for the Accuryn Monitoring System and associated products covered by the agreement. According to the company, the deal creates a purchasing pathway for hospitals seeking to implement advanced kidney health and fluid monitoring.

“We are pleased to enter into this agreement with Vizient and expand access to technology that supports monitoring for acute kidney injury,” says Mike Schrader, CEO of Accuryn Medical, in a release. “Changes in urine output can provide an early indication of acute kidney injury (AKI) and kidney distress, but intermittent measurements can make those changes difficult to recognize promptly. Accuryn gives care teams continuous visibility into urine output to support earlier recognition and informed clinical decisions.”

How the Accuryn Monitoring System Works

The Accuryn Monitoring System automates urine output measurement and provides real-time trends and alerts based on urine output guidelines established by Kidney Disease: Improving Global Outcomes criteria. The company says these capabilities support clinicians as they assess critically ill patients for acute kidney injury and monitor changes over time.

The system combines smart urinary catheter technology with urine output monitoring, core body temperature measurement, and continuous intra-abdominal pressure monitoring.

Hospitals interested in product availability, contract pricing activation, or a demonstration can contact Accuryn Medical, according to the company. Accuryn is based in Hayward, California.

Photo caption: Accuryn Monitoring System

Photo credit: Accuryn